Processa Pharmaceuticals, Inc.
Monday, February 26, 2024
Uris
Oncology
Processa Pharmaceuticals is a clinical stage pharmaceutical company developing Next Generation Chemotherapies (NGCs) to address the underlying challenges of current drugs by modifying pharmacokinetics to improve efficacy and toxicity leading to longer survival and enhanced quality of life for people with cancer.
State
MD
Country
United States
Website
http://www.processapharma.com
CEO/Top Company Official
George Ng
Lead Product in Development
6422
Development Phase of Primary Product
Phase I
Number Of Unlicensed Products
2
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
)
)
){kind=logo}